Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 66 referenced papers

Top Authors

Jun Sone
Aichi Medical University
Yun Tian
Central South University
Daojun Hong
First Affiliated Hospital of Nanchang University
Lu Hua Shen
Central South University
Jianwen Deng
Peking University First Hospital
Zhaoxia Wang
Peking University First Hospital
Shaoping Zhong
Fudan University
Xin Wang
Shanghai Medical College of Fudan University
Yangye Lian
Fudan University
Jing Ding
Shanghai Medical College of Fudan University

Top Institutions

Ranked by publications Top 10 institutions
01

Shanghai Medical College of Fudan University

Shanghai, China

16 papers
04

Peking University First Hospital

Beijing, China

29 papers
05
06

First Affiliated Hospital of Nanchang University

Nanchang, China

22 papers
07

Second Affiliated Hospital of Zhejiang University

Hangzhou, China

14 papers
08

Capital Medical University

Beijing, China

19 papers
09

Shanghai Jiao Tong University

Shanghai, China

18 papers

References

References (66)
  1. 1

    Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

    Sone J, Mori K, Inagaki T, et al.

    Brain : a journal of neurology 2016; (139(Pt 12)):3170-3186 doi:10.1093/brain/aww249.

    PMID: 27797808
  2. 2

    [Adult-Onset Neuronal Intranuclear Inclusion Disease in Two Female Siblings].

    Yoshimoto T, Takamatsu K, Kurashige T, et al.

    Brain and nerve = Shinkei kenkyu no shinpo 2017; (69(3)):267-274 doi:10.11477/mf.1416200737.

    PMID: 28270636
  3. 3

    Two cases of sporadic adult-onset neuronal intranuclear inclusion disease preceded by urinary disturbance for many years.

    Nakamura M, Ueki S, Kubo M, et al.

    Journal of the neurological sciences 2018; (392()):89-93 doi:10.1016/j.jns.2018.07.012.

    PMID: 30031993
  4. 4

    Non-convulsive status epilepticus associated with neuronal intranuclear inclusion disease: A case report and literature review.

    Shindo K, Tsuchiya M, Hata T, et al.

    Epilepsy & behavior case reports 2019; (11()):103-106 doi:10.1016/j.ebcr.2019.01.007.

    PMID: 30891404
  5. 5

    [Neuronal intranuclear inclusion disease with prolonged impaired consciousness and status epilepticus: a case report].

    Yamanaka H, Hashimoto S, Suenaga T

    Rinsho shinkeigaku = Clinical neurology 2019; (59(7)):425-430 doi:10.5692/clinicalneurol.cn-001264.

    PMID: 31243248
  6. 6

    Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

    Vermilion J, Johnson M, Srinivasan J, Mink JW

    Journal of child neurology 2019; (34(13)):801-805 doi:10.1177/0883073819860566.

    PMID: 31304825
  7. 7

    Diagnostic indicators for adult-onset neuronal intranuclear inclusion disease.

    Wang Y, Wang B, Wang L, et al.

    Clinical neuropathology 2020; (39(1)):7-18 doi:10.5414/NP301203.

    PMID: 31661069
  8. 8

    Adult-onset neuronal intranuclear inclusion disease presenting with typical MRI changes.

    Han X, Han M, Liu N, et al.

    Brain and behavior 2019; (9(12)):e01477 doi:10.1002/brb3.1477.

    PMID: 31749292
  9. 9

    Multiple reversible encephalitic attacks: a rare manifestation of neuronal intranuclear inclusion disease.

    Li M, Li K, Li X, et al.

    BMC neurology 2020; (20(1)):125 doi:10.1186/s12883-020-01712-5.

    PMID: 32268889
  10. 10

    Clinical and pathological features in adult-onset NIID patients with cortical enhancement.

    Liang H, Wang B, Li Q, et al.

    Journal of neurology 2020; (267(11)):3187-3198 doi:10.1007/s00415-020-09945-7.

    PMID: 32535679
  11. 11

    Neuronal intranuclear inclusion disease presenting with dysphagia: a report of three cases.

    Aoyagi Y, Taya M, Ohashi M, Saitoh E

    Neurocase 2020; (26(4)):252-257 doi:10.1080/13554794.2020.1788607.

    PMID: 32619141
  12. 12

    Urodynamic Assessment of Neuronal Intranuclear Inclusion Disease.

    Aiba Y, Sakakibara R, Lee FC, Tateno F

    European neurology 2020; (83(3)):312-316 doi:10.1159/000508746.

    PMID: 32645705
  13. 13

    Neuronal intranuclear inclusion disease: two case report and literature review.

    Qin X, Chen H, Zhou C, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(1)):293-296 doi:10.1007/s10072-020-04613-0.

    PMID: 32839883
  14. 14

    Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis.

    Yuan Y, Liu Z, Hou X, et al.

    Neurology 2020; (95(24)):e3394-e3405 doi:10.1212/WNL.0000000000010945.

    PMID: 32989102
  15. 15

    [Neuronal intranuclear inclusion disease: a clinicopathological study of two cases].

    Wu N, Wang X, Zhang RS, et al.

    Zhonghua bing li xue za zhi = Chinese journal of pathology 2020; (49(10)):1031-1035 doi:10.3760/cma.j.cn112151-20200428-00347.

    PMID: 32992418
  16. 16

    Genetic and Pathological Characteristic Patterns of a Family With Neuronal Intranuclear Inclusion Disease.

    Zhang S, Gong Q, Wu D, et al.

    Journal of neuropathology and experimental neurology 2020; (79(12)):1293-1302 doi:10.1093/jnen/nlaa142.

    PMID: 33271601
  17. 17

    Neuronal intranuclear inclusion disease: recognition and update.

    Lu X, Hong D

    Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(3)):295-303 doi:10.1007/s00702-021-02313-3.

    PMID: 33599827
  18. 18

    Expanding the clinical spectrum of adult-onset neuronal intranuclear inclusion disease.

    Cao Y, Wu J, Yue Y, et al.

    Acta neurologica Belgica 2022; (122(3)):647-658 doi:10.1007/s13760-021-01622-4.

    PMID: 33625684
  19. 19

    Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease.

    Deng J, Zhou B, Yu J, et al.

    Journal of medical genetics 2022; (59(5)):462-469 doi:10.1136/jmedgenet-2020-107649.

    PMID: 33766934
  20. 20

    The Value of NOTCH2NLC Gene Detection and Skin Biopsy in the Diagnosis of Neuronal Intranuclear Inclusion Disease.

    Pang J, Yang J, Yuan Y, et al.

    Frontiers in neurology 2021; (12()):624321 doi:10.3389/fneur.2021.624321.

    PMID: 34017298
  21. 21

    FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report.

    Toko M, Ohshita T, Kurashige T, et al.

    BMC neurology 2021; (21(1)):396 doi:10.1186/s12883-021-02425-z.

    PMID: 34641814
  22. 22

    NOTCH2NLC-related disorders: the widening spectrum and genotype-phenotype correlation.

    Fan Y, Xu Y, Shi C

    Journal of medical genetics 2022; (59(1)):1-9 doi:10.1136/jmedgenet-2021-107883.

    PMID: 34675123
  23. 23

    Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases.

    Zhong S, Lian Y, Luo W, et al.

    Acta neuropathologica 2021; (142(6)):1003-1023 doi:10.1007/s00401-021-02375-3.

    PMID: 34694469
  24. 24

    Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing.

    Fukuda H, Yamaguchi D, Nyquist K, et al.

    Clinical epigenetics 2021; (13(1)):204 doi:10.1186/s13148-021-01192-5.

    PMID: 34774111
  25. 25

    Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy.

    Liu YH, Chou YT, Chang FP, et al.

    Brain : a journal of neurology 2022; (145(9)):3010-3021 doi:10.1093/brain/awac135.

    PMID: 35411397
  26. 26

    [Neuronal intranuclear inclusion disease in a patient who exhibited abnormal behavior].

    Ueda R, Koizumi T, Mizuno T, Nakagawa M

    Rinsho shinkeigaku = Clinical neurology 2022; (62(5)):369-374 doi:10.5692/clinicalneurol.cn-001689.

    PMID: 35474285
  27. 27

    Case report: Adult-onset neuronal intranuclear inclusion disease with an amyotrophic lateral sclerosis phenotype.

    Fujita M, Ueno T, Miki Y, et al.

    Frontiers in neuroscience 2022; (16()):960680 doi:10.3389/fnins.2022.960680.

    PMID: 36033605
  28. 28

    Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease.

    Tian Y, Zhou L, Gao J, et al.

    Journal of neurology, neurosurgery, and psychiatry 2022; (93(12)):1289-1298 doi:10.1136/jnnp-2022-329772.

    PMID: 36150844
  29. 29

    Subclinical peripheral neuropathy is common in neuronal intranuclear inclusion disease with dominant encephalopathy.

    Hong D, Wang H, Zhu M, et al.

    European journal of neurology 2023; (30(2)):527-537 doi:10.1111/ene.15606.

    PMID: 36263606
  30. 30

    Perfusion abnormality in neuronal intranuclear inclusion disease with stroke-like episode: A case report.

    Kutsuna F, Tateishi Y, Yamashita K, et al.

    Cerebral circulation - cognition and behavior 2022; (3()):100127 doi:10.1016/j.cccb.2022.100127.

    PMID: 36324394
  31. 31

    Unraveling rare form of adult-onset NIID by characteristic brain MRI features: A single-center retrospective review.

    Li F, Wang Q, Zhu Y, et al.

    Frontiers in neurology 2022; (13()):1085283 doi:10.3389/fneur.2022.1085283.

    PMID: 36588885
  32. 32

    Current advances in neuronal intranuclear inclusion disease.

    Bao L, Zuo D, Li Q, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(6)):1881-1889 doi:10.1007/s10072-023-06677-0.

    PMID: 36795299
  33. 33

    Clinical Features and Classification of Neuronal Intranuclear Inclusion Disease.

    Tai H, Wang A, Zhang Y, et al.

    Neurology. Genetics 2023; (9(2)):e200057 doi:10.1212/NXG.0000000000200057.

    PMID: 37090934
  34. 34

    The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation.

    Yan Y, Cao L, Gu L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(9)):3189-3197 doi:10.1007/s10072-023-06822-9.

    PMID: 37099235
  35. 35

    A comprehensive study of clinicopathological and genetic features of neuronal intranuclear inclusion disease.

    Liu M, Gao Y, Yuan Y, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(10)):3545-3556 doi:10.1007/s10072-023-06845-2.

    PMID: 37184590
  36. 36

    Rapidly progressive adult-onset neuronal intranuclear inclusion disease beginning with autonomic symptoms: a case report.

    Zhu Y, Yang Q, Tian Y, et al.

    Frontiers in neurology 2023; (14()):1190981 doi:10.3389/fneur.2023.1190981.

    PMID: 37305750
  37. 37

    Characteristics of autonomic dysfunction in neuronal intranuclear inclusion disease.

    Zhou L, Tian Y, Zhang S, et al.

    Frontiers in neurology 2023; (14()):1168904 doi:10.3389/fneur.2023.1168904.

    PMID: 37388545
  38. 38

    Longitudinal course of hyperintensity on diffusion weighted imaging in adult-onset neuronal intranuclear inclusion disease patients.

    Liu D, Chen K, Tan S, et al.

    Frontiers in neurology 2023; (14()):1178307 doi:10.3389/fneur.2023.1178307.

    PMID: 37404945
  39. 39

    Diagnostic value of nerve conduction study in NOTCH2NLC-related neuronal intranuclear inclusion disease.

    Tian Y, Hou X, Cao W, et al.

    Journal of the peripheral nervous system : JPNS 2023; (28(4)):629-641 doi:10.1111/jns.12599.

    PMID: 37749855
  40. 40

    Neuronal Intranuclear Inclusion Disease with NOTCH2NLC GGC Repeat Expansion: A Systematic Review and Challenges of Phenotypic Characterization.

    Zeng T, Chen Y, Huang H, et al.

    Aging and disease 2024; (16(1)):578-597 doi:10.14336/AD.2024.0131-1.

    PMID: 38377026
  41. 41

    Neuronal intranuclear inclusion disease misdiagnosed as Parkinson's disease: a case report.

    Yu D, Li J, Tai H, et al.

    The Journal of international medical research 2024; (52(3)):3000605241233159 doi:10.1177/03000605241233159.

    PMID: 38436278
  42. 42

    Encephalitis-like episodes with cortical edema and enhancement in patients with neuronal intranuclear inclusion disease.

    Shen Y, Jiang K, Liang H, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(9)):4501-4511 doi:10.1007/s10072-024-07492-x.

    PMID: 38532189
  43. 43

    Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease.

    Miyaue N, Ochi C, Ito YH, et al.

    Internal medicine (Tokyo, Japan) 2024; (63(8)):1163-1166 doi:10.2169/internalmedicine.2384-23.

    PMID: 38616117
  44. 44

    Clinical features of neuronal intranuclear inclusion disease with seizures: a systematic literature review.

    Zhang J, Ling L, Xiang L, et al.

    Frontiers in neurology 2024; (15()):1387399 doi:10.3389/fneur.2024.1387399.

    PMID: 38707999
  45. 45

    Prevalence and Characterization of NOTCH2NLC GGC Repeat Expansions in Koreans: From a Hospital Cohort Analysis to a Population-Wide Study.

    Lee S, Yoon JG, Hong J, et al.

    Neurology. Genetics 2024; (10(3)):e200147 doi:10.1212/NXG.0000000000200147.

    PMID: 38779172
  46. 46

    Nerve conduction features may serve as a diagnostic clue for neuronal intranuclear inclusion disease.

    Jih KY, Lan MY, Liu YH, et al.

    Brain communications 2024; (6(4)):fcae221 doi:10.1093/braincomms/fcae221.

    PMID: 38978725
  47. 47

    Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease.

    Zhong S, Lian Y, Zhou B, et al.

    Acta neuropathologica 2024; (148(1)):21 doi:10.1007/s00401-024-02776-0.

    PMID: 39150562
  48. 48

    Stroke-like episodes in patients with adult-onset neuronal intranuclear inclusion disease and patients with late-onset MELAS: A comparative study.

    Shi Y, Dong G, Pan H, et al.

    Annals of clinical and translational neurology 2024; (11(12)):3125-3136 doi:10.1002/acn3.52219.

    PMID: 39367621
  49. 49

    Familial adult-onset neuronal intranuclear inclusion disease: A case report and literature review.

    Wei L, Wang J, Xu C, et al.

    Medicine 2024; (103(44)):e40279 doi:10.1097/MD.0000000000040279.

    PMID: 39496005
  50. 50

    Neuronal Intranuclear Inclusion Disease Presenting with Acute-Onset Dementia and Cortical Edema: A Case Report.

    Feng X, Li Y, Zhao Q, Xu S

    Frontiers in neurology 2024; (15()):1464991 doi:10.3389/fneur.2024.1464991.

    PMID: 39529621
  51. 51

    Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report.

    Sun L, Zhou L, Ren L, et al.

    Medicine 2024; (103(47)):e40636 doi:10.1097/MD.0000000000040636.

    PMID: 39809216
  52. 52

    Spatial and Temporal Distribution of White Matter Lesions in NOTCH2NLC-Related Neuronal Intranuclear Inclusion Disease.

    Zhong S, Fei B, Liang J, et al.

    Neurology 2025; (104(4)):e213360 doi:10.1212/WNL.0000000000213360.

    PMID: 39899794
  53. 53

    Detection and characterization of rare variants in NOTCH2NLC causing false negative molecular diagnosis through long-read sequencing.

    Zheng X, Jin N, Liu P, et al.

    European journal of human genetics : EJHG 2025; (33(9)):1207-1211 doi:10.1038/s41431-025-01892-z.

    PMID: 40514451
  54. 54

    Psychiatric-onset neuronal intranuclear inclusion disease in a psychiatry-based dementia-enriched cohort in Japan.

    Miyamoto T, Mori K, Akamine S, et al.

    Psychiatry and clinical neurosciences 2025; (79(9)):561-571 doi:10.1111/pcn.13854.

    PMID: 40515658
  55. 55

    Diverse Clinical Phenotypes of Neuronal Intranuclear Inclusion Disease in South Korea.

    Chun MY, Seo SW, Jang H, et al.

    Journal of clinical neurology (Seoul, Korea) 2025; (21(4)):315-324 doi:10.3988/jcn.2024.0526.

    PMID: 40635536
  56. 56

    Neuronal intranuclear inclusion disease with recurrent encephalitis.

    Li C, Zhao C, Quan C, et al.

    BMC neurology 2025; (25(1)):442 doi:10.1186/s12883-025-04453-5.

    PMID: 41146043
  57. 57

    Episodic encephalopathy in NOTCH2NLC-related neuronal intranuclear inclusion disease: Clinical spectrum and a proposed classification framework.

    Liang J, Zhong S, Lian Y, et al.

    Journal of the neurological sciences 2026; (480()):125706 doi:10.1016/j.jns.2025.125706.

    PMID: 41455460
  58. 58

    Neuronal intranuclear inclusion disease with stroke-mimicking onset: a case report and systematic review.

    Cai H, Fan Y, Yu Y, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):175.

    PMID: 41549140
  59. 59

    Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report.

    Zang P, Liu Y, Hao Y

    BMC neurology 2026; (26(1)).

    PMID: 41634634
  60. 60

    Case Report: Distinctive features of cognitive dysfunction and amelioration by antiseizure medication in neuronal intranuclear inclusion disease.

    Ohara H, Yamanaka M, Okada F, et al.

    Frontiers in neuroscience 2026; (20()):1734078 doi:10.3389/fnins.2026.1734078.

    PMID: 41716662
  61. 61

    Adult-onset neuronal intranuclear inclusion disease initially presenting with prominent gastrointestinal symptoms: a case report.

    Yuan X, Yang Y, Tang Y, Luo Q

    BMC neurology 2026; (26(1)).

    PMID: 41845318
  62. 62

    Clinical and imaging characteristics of NOTCH3-negative CADASIL-suspected patients with NOTCH2NLC GGC repeat expansions.

    Matsuura H, Fukunaga D, Mizuta I, et al.

    Journal of human genetics 2026; (71(8)):479-484 doi:10.1038/s10038-026-01470-1.

    PMID: 41882342
  63. 63

    Adult-Onset Neuronal Intranuclear Inclusion Disease Initially Manifesting as Bladder Dysfunction: A Case Report.

    Yamaki A, Sekino H, Kawana S, et al.

    Cureus 2026; (18(3)):e105488 doi:10.7759/cureus.105488.

    PMID: 42005169
  64. 64

    A Case of Neuronal Intranuclear Inclusion Disease Mimicking Acute Stroke.

    Yoshimura J, Hayashi T, Kashimoto Y, et al.

    Internal medicine (Tokyo, Japan) 2026; doi:10.2169/internalmedicine.6946-25.

    PMID: 42021030
  65. 65

    Re-evaluating archival specimens as a pathologic diagnostic resource for neuronal intranuclear inclusion disease.

    Lian Y, Zhong S, Liang J, et al.

    American journal of clinical pathology 2026; (165(5)) doi:10.1093/ajcp/aqag041.

    PMID: 42177789
  66. 66

    Case Report: Neuronal intranuclear inclusion disease mimicking recurrent stroke in the setting of intracranial stenosis.

    Zhao J, Shen G, Chi L

    Frontiers in medicine 2026; (13()):1838444 doi:10.3389/fmed.2026.1838444.

    PMID: 42245955